CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol(Registered) Cyclo(TradeMark) for Treatment of Niemann-Pick Disease Type C

Press/Media: Press / Media

PeriodOct 7 2018

Media coverage

1

Media coverage

  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol(Registered) Cyclo(TradeMark) for Treatment of Niemann-Pick Disease Type C
    Media name/outletNews Bites US Markets
    CountryUnited States
    Date10/7/18
    PersonsDarius Adams